New hope for nigerian women: targeted breast cancer therapy before and after surgery

NCT ID NCT06348134

First seen Feb 21, 2026 · Last updated May 08, 2026 · Updated 8 times

Summary

This study is for Nigerian women with a specific type of breast cancer called HER2-positive. Doctors want to see if giving a combination of targeted drugs before and after surgery can destroy the cancer completely. About 74 women will receive the treatment, and researchers will check for side effects and how well the cancer responds.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Lagos State University Teaching Hospital

    RECRUITING

    Ikeja, Lagos, 100271, Nigeria

    Contact Phone: •••-•••-••••

    Contact

    Contact Phone: •••-•••-••••

  • Lagos University Teaching Hospital

    RECRUITING

    Yaba, Lagos, 100254, Nigeria

    Contact Phone: •••-•••-••••

    Contact Phone: •••-•••-••••

    Contact

  • Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC)

    RECRUITING

    Ile-Ife, Osun State, 220005, Nigeria

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Ibadan Hospital

    RECRUITING

    Ibadan, Oyo State, 200285, Nigeria

    Contact Phone: •••-•••-••••

    Contact

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.